AFGGX
Price
$23.90
Change
-$0.19 (-0.79%)
Updated
Jul 10 closing price
Net Assets
125.07M
RSLEX
Price
$82.59
Change
-$0.07 (-0.08%)
Updated
Jul 10 closing price
Net Assets
94.26B
Interact to see
Advertisement

AFGGX vs RSLEX

AFGGX vs RSLEX Comparison Chart in %
View a ticker or compare two or three
VS
AFGGX vs. RSLEX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFGGX is a StrongBuy and RSLEX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLEX has more cash in the bank: 94.3B vs. AFGGX (125M). RSLEX pays higher dividends than AFGGX: RSLEX (0.59) vs AFGGX (0.00). AFGGX was incepted earlier than RSLEX: AFGGX (22 years) vs RSLEX (24 years). AFGGX (1.28) is less costly to investors than RSLEX (1.00). RSLEX is a more actively managed with annual turnover of: 41.00 vs. AFGGX (38.00). RSLEX has a lower initial minimum investment than AFGGX: RSLEX (250) vs AFGGX (1000). AFGGX annual gain was more profitable for investors over the last year : 26.66 vs. RSLEX (13.79). AFGGX return over 5 years is better than : 18.44 vs. RSLEX (-4.03).
AFGGXRSLEXAFGGX / RSLEX
Total Expense Ratio1.261.00126%
Annual Report Gross Expense Ratio1.281.00128%
Fund Existence22 years24 years-
Gain YTD17.79212.037148%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets125M94.3B0%
Annual Yield % from dividends0.000.59-
Returns for 1 year26.6613.79193%
Returns for 3 years47.9430.08159%
Returns for 5 years18.44-4.03-457%
Returns for 10 years63.4687.4473%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FRIAX2.52N/A
N/A
Franklin Income Adv
GSMYX25.93N/A
N/A
Goldman Sachs Small/Mid Cap Growth Instl
RLAIX24.27N/A
N/A
T. Rowe Price Latin America I
BDBPX32.05N/A
N/A
iShares Russell 2000 Small-Cap Idx Inv P
MCYCX15.72-0.49
-3.02%
NYLI Candriam Emerging Markets Eq Cl C